Boston Scientific Corp. put a pair of its cardiac rhythm devices on the market in Japan.
The Natick, Mass.-based medical device-making monolith said it launched its Cognis cardiac resynchronization therapy defibrillator and Teligen implantable cardioverter defibrillator in the Land of the Rising Sun, after landing approval from the Japanese Ministry of Health, Labor and Welfare in August and reimbursement approval in September.